{"id":"https://openalex.org/W2983172312","doi":"https://doi.org/10.1182/blood-2019-128521","title":"The Landscape of Genome Wide Somatic Alterations Identifies a Good-Risk Group in Newly Diagnosed Multiple Myeloma","display_name":"The Landscape of Genome Wide Somatic Alterations Identifies a Good-Risk Group in Newly Diagnosed Multiple Myeloma","publication_year":2019,"publication_date":"2019-11-13","ids":{"openalex":"https://openalex.org/W2983172312","doi":"https://doi.org/10.1182/blood-2019-128521","mag":"2983172312"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2019-128521","doi":"https://doi.org/10.1182/blood-2019-128521","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2019-128521","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041668980","display_name":"Mehmet Samur","orcid":"https://orcid.org/0000-0002-9978-5682","observed_orcids":["https://orcid.org/0000-0002-9978-5682"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mehmet Kemal Samur","raw_affiliation_strings":["Department of Data Science, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health, Boston, MA","The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Data Science, Dana-Farber Cancer Institute, Harvard TH Chan School of Public Health, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067318207","display_name":"An\u0131l Akta\u015f Samur","orcid":"https://orcid.org/0000-0002-0183-0562","observed_orcids":["https://orcid.org/0000-0002-0183-0562"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anil Aktas Samur","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA","Harvard School of Public Health, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Harvard School of Public Health, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039380390","display_name":"Tessa Han","orcid":"https://orcid.org/0000-0001-7877-6210","observed_orcids":["https://orcid.org/0000-0001-7877-6210"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tessa Han","raw_affiliation_strings":["Harvard University, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard University, Cambridge, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031149500","display_name":"Marco Roncador","orcid":"https://orcid.org/0000-0002-4574-4703","observed_orcids":["https://orcid.org/0000-0002-4574-4703"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marco Roncador","raw_affiliation_strings":["Dana-Farber Cancer Institute, Brookline, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Brookline, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062468245","display_name":"Mariateresa Fulciniti","orcid":"https://orcid.org/0000-0002-1432-9742","observed_orcids":["https://orcid.org/0000-0002-1432-9742"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mariateresa Fulciniti","raw_affiliation_strings":["The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055748047","display_name":"Raphael Elie Szalat","orcid":"https://orcid.org/0000-0002-6198-3405","observed_orcids":["https://orcid.org/0000-0002-6198-3405"]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raphael Szalat","raw_affiliation_strings":["Boston University School of Medicine, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston University School of Medicine, Boston, MA","institution_ids":["https://openalex.org/I111088046"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063099799","display_name":"Masood A. Shammas","orcid":"https://orcid.org/0000-0002-8932-6829","observed_orcids":["https://orcid.org/0000-0002-8932-6829"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Masood A. Shammas","raw_affiliation_strings":["The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston,","VA Boston Healthcare System, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston,","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030565933","display_name":"Jill Corre","orcid":"https://orcid.org/0000-0003-1580-6106","observed_orcids":["https://orcid.org/0000-0003-1580-6106"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jill Corre","raw_affiliation_strings":["Unite de Genomique du Myelome, IUC-T Oncopole, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unite de Genomique du Myelome, IUC-T Oncopole, Toulouse, France","institution_ids":["https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043526996","display_name":"Paul Gerard Guy Richardson","orcid":"https://orcid.org/0000-0002-7426-8865","observed_orcids":["https://orcid.org/0000-0002-7426-8865"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul G. Richardson","raw_affiliation_strings":["Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041002394","display_name":"Florence Magrangeas","orcid":"https://orcid.org/0000-0002-5031-3748","observed_orcids":["https://orcid.org/0000-0002-5031-3748"]},"institutions":[{"id":"https://openalex.org/I4405260337","display_name":"Universit\u00e9 de Nantes","ror":"https://ror.org/03kjmz544","country_code":"FR","type":"education","lineage":["https://openalex.org/I4405260337","https://openalex.org/I97188460"]},{"id":"https://openalex.org/I97188460","display_name":"Nantes Universit\u00e9","ror":"https://ror.org/03gnr7b55","country_code":"FR","type":"education","lineage":["https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Florence Magrangeas","raw_affiliation_strings":["Universit\u00e9 de Nantes, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e9 de Nantes, Nantes, France","institution_ids":["https://openalex.org/I4405260337","https://openalex.org/I97188460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073612758","display_name":"St\u00e9phane Minvielle","orcid":"https://orcid.org/0000-0003-1389-312X","observed_orcids":["https://orcid.org/0000-0003-1389-312X"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210092509","display_name":"Centre de Recherche en Canc\u00e9rologie et Immunologie Int\u00e9gr\u00e9e Nantes Angers","ror":"https://ror.org/003g1aw90","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I3019204325","https://openalex.org/I4210092509","https://openalex.org/I4210096427","https://openalex.org/I4210106090","https://openalex.org/I4210112910","https://openalex.org/I49451733","https://openalex.org/I97188460"]},{"id":"https://openalex.org/I4405260337","display_name":"Universit\u00e9 de Nantes","ror":"https://ror.org/03kjmz544","country_code":"FR","type":"education","lineage":["https://openalex.org/I4405260337","https://openalex.org/I97188460"]},{"id":"https://openalex.org/I97188460","display_name":"Nantes Universit\u00e9","ror":"https://ror.org/03gnr7b55","country_code":"FR","type":"education","lineage":["https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Stephane Minvielle","raw_affiliation_strings":["CRCINA, INSERM, CNRS, Angers University and Nantes University, Nantes, France","CRCINA, INSERM, CNRS, Universite de Nantes, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CRCINA, INSERM, CNRS, Angers University and Nantes University, Nantes, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4210092509","https://openalex.org/I4405260337"]},{"raw_affiliation_string":"CRCINA, INSERM, CNRS, Universite de Nantes, Nantes, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4405260337","https://openalex.org/I97188460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103143602","display_name":"Philippe Moreau","orcid":"https://orcid.org/0000-0003-1780-8746","observed_orcids":["https://orcid.org/0000-0003-1780-8746"]},"institutions":[{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]},{"id":"https://openalex.org/I97188460","display_name":"Nantes Universit\u00e9","ror":"https://ror.org/03gnr7b55","country_code":"FR","type":"education","lineage":["https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Philippe Moreau","raw_affiliation_strings":["Clinical Hematology, University Hospital H\u00f4tel-Dieu, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Hematology, University Hospital H\u00f4tel-Dieu, Nantes, France","institution_ids":["https://openalex.org/I3019204325","https://openalex.org/I97188460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025996929","display_name":"Michel Attal","orcid":"https://orcid.org/0000-0002-0136-9665","observed_orcids":["https://orcid.org/0000-0002-0136-9665"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Michel Attal","raw_affiliation_strings":["Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France","institution_ids":["https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028526208","display_name":"Anjan Thakurta","orcid":"https://orcid.org/0000-0003-0415-1706","observed_orcids":["https://orcid.org/0000-0003-0415-1706"]},"institutions":[{"id":"https://openalex.org/I4387155837","display_name":"Celgene (United States)","ror":"https://ror.org/0527yg379","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812","https://openalex.org/I4387155837"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anjan Thakurta","raw_affiliation_strings":["Celgene Corporation, Summit, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene Corporation, Summit, NJ","institution_ids":["https://openalex.org/I4387155837"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032464400","display_name":"Kenneth Carl Anderson","orcid":"https://orcid.org/0000-0002-6418-0886","observed_orcids":["https://orcid.org/0000-0002-6418-0886"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth C. Anderson","raw_affiliation_strings":["Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050977500","display_name":"Giovanni Parmigiani","orcid":"https://orcid.org/0000-0002-8783-5961","observed_orcids":["https://orcid.org/0000-0002-8783-5961"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Giovanni Parmigiani","raw_affiliation_strings":["Harvard T.H. Chan School of Public Health, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard T.H. Chan School of Public Health, Boston, MA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063422967","display_name":"Herv\u00e9 Avet\u2010Loiseau","orcid":"https://orcid.org/0000-0002-3050-0140","observed_orcids":["https://orcid.org/0000-0002-3050-0140"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Herve Avet-Loiseau","raw_affiliation_strings":["Insititut Universitaire du Cancer, Unite de Genomique du Myelome, IUC-Oncopole, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Insititut Universitaire du Cancer, Unite de Genomique du Myelome, IUC-Oncopole, Toulouse, France","institution_ids":["https://openalex.org/I4210098740"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045740077","display_name":"Nikhil C. Munshi","orcid":"https://orcid.org/0000-0002-7344-9795","observed_orcids":["https://orcid.org/0000-0002-7344-9795","https://orcid.org/0000-0002-8397-100X"]},"institutions":[{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikhil C. Munshi","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA","VA Boston Healthcare System, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":13,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"134","issue":"Supplement_1","first_page":"3055","last_page":"3055"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.800000011920929},{"id":"https://openalex.org/keywords/mutational-signatures","display_name":"mutational signatures","score":0.8320000171661377},{"id":"https://openalex.org/keywords/apobec-mutagenesis","display_name":"APOBEC mutagenesis","score":0.6620000004768372},{"id":"https://openalex.org/keywords/copy-number-alterations","display_name":"copy number alterations","score":0.8209999799728394},{"id":"https://openalex.org/keywords/mutational-load","display_name":"mutational load","score":0.6660000085830688},{"id":"https://openalex.org/keywords/clonal-evolution","display_name":"clonal evolution","score":0.6159999966621399},{"id":"https://openalex.org/keywords/subclonal-mutations","display_name":"subclonal mutations","score":0.7649999856948853},{"id":"https://openalex.org/keywords/homologous-recombination","display_name":"homologous recombination","score":0.7950000166893005},{"id":"https://openalex.org/keywords/nucleotide-excision-repair","display_name":"nucleotide excision repair","score":0.9549999833106995},{"id":"https://openalex.org/keywords/dna-repair","display_name":"DNA repair","score":0.4779999852180481},{"id":"https://openalex.org/keywords/somatic-hypermutation","display_name":"somatic hypermutation","score":0.6859999895095825},{"id":"https://openalex.org/keywords/5-methylcytosine-deamination","display_name":"5-methylcytosine deamination","score":0.7599999904632568}],"concepts":[{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.5654745101928711},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5310877561569214},{"id":"https://openalex.org/C141231307","wikidata":"https://www.wikidata.org/wiki/Q7020","display_name":"Genome","level":3,"score":0.47341567277908325},{"id":"https://openalex.org/C2779399171","wikidata":"https://www.wikidata.org/wiki/Q1483951","display_name":"Malignancy","level":2,"score":0.4700661599636078},{"id":"https://openalex.org/C2776162770","wikidata":"https://www.wikidata.org/wiki/Q4653351","display_name":"APOBEC","level":4,"score":0.46468308568000793},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.44141528010368347},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.4356020987033844},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.40263867378234863},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38941705226898193},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3445080518722534},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.305672824382782},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2181251347064972},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2037191390991211},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2019-128521","doi":"https://doi.org/10.1182/blood-2019-128521","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2019-128521","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9969000220298767}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3043473017","https://openalex.org/W2583368532","https://openalex.org/W2909832309","https://openalex.org/W2559098034","https://openalex.org/W2569968610","https://openalex.org/W2563678684","https://openalex.org/W2224927009","https://openalex.org/W4389234553","https://openalex.org/W3097738629","https://openalex.org/W2561597044"],"abstract_inverted_index":{"Multiple":[0],"Myeloma":[1],"(MM)":[2],"is":[3,560],"a":[4,45,50,77,543,555,564],"plasma":[5],"cells":[6,251],"malignancy":[7],"with":[8,18,81,225,279,357,369,577],"number":[9,107,138,324,338],"of":[10,38,47,56,79,108,193,234,307,348,378,405,573,600,611,624,635,646,663,676],"recent":[11],"therapeutic":[12],"options":[13],"that":[14,331,352,431,559],"has":[15,27,65],"improved":[16],"outcomes":[17],"median":[19],"survival":[20,52,373],"now":[21],"stretching":[22],"beyond":[23],"8":[24],"years.":[25],"There":[26],"been":[28,67],"an":[29,597,608,621,632,643,660,673],"intense":[30],"search":[31],"to":[32,161,195,465,536,562],"identify":[33,554],"genomic":[34,54,545],"and":[35,101,112,125,164,210,219,229,254,262,283,361,399,429,433,440,550,553],"laboratory":[36],"correlates":[37],"outcome":[39,341,368],"for":[40,184,376,472,500,579],"high":[41,199],"risk":[42],"patients.":[43],"However,":[44,276],"subgroup":[46],"patients":[48,80,93,155,356,461],"have":[49,85,366,563],"long":[51,82,565],"but":[53],"segmentation":[55],"this":[57,312,349,377,393,414,537],"important":[58],"group":[59,525,558],"which":[60],"can":[61],"be":[62],"potentially":[63],"cured":[64],"not":[66],"identified.":[68],"We":[69,84,329,390,419],"here":[70],"described":[71,446],"first":[72],"such":[73],"attempt":[74],"at":[75],"identifying":[76],"subset":[78],"survival.":[83,566],"analyzed":[86],"data":[87,350,423],"from":[88,326],"205":[89],"newly-diagnosed":[90],"uniformly-treated":[91],"MM":[92,131,153,209,235,308,355,359],"using":[94,322,335,395,547],"both":[95,584],"deep":[96,548],"whole":[97,102],"genome":[98],"(WGS)":[99],"(80x)":[100],"transcriptome":[103],"sequencing":[104,552],"(RNAseq).":[105],"Median":[106],"SNVs,":[109],"small":[110],"insertion":[111],"deletion":[113],"per":[114,171],"megabase":[115,172],"were":[116,238,289,454,463,519],"2.18":[117],"[0.49":[118],"-":[119,123,128],"14.52],":[120],"0.077":[121],"[0.024":[122],"0.17]":[124],"0.12":[126],"[0.03":[127],"0.26]":[129],"respectively.":[130],"subgroups":[132,163,179],"defined":[133,427],"by":[134,240,447,516],"FISH":[135],"or":[136,242,602,613,626,637,648,665,678],"copy":[137,323,337],"alterations":[139,325],"(CNAs)":[140],"had":[141,156,166,468],"significantly":[142,198,214,290,520],"different":[143,215],"mutational":[144,169,185],"load":[145,159,170],"(Kruskal-Wallis":[146],"p-value":[147],"=":[148,388,411,452],"0.003).":[149],"In":[150,509,539],"general,":[151],"Hyperdiploid":[152],"(HMM)":[154,360],"lower":[157,469,521],"SNV":[158],"compared":[160],"other":[162],"t(14;16)":[165,208],"the":[167,222,269,293,317,523,571],"highest":[168],"(Dunn":[173],"test":[174,385,408],"FDR":[175,477,484,492],"<":[176,260,299,438,478,485,493,507,531],"0.25).":[177],"These":[178],"also":[180,569],"showed":[181],"significant":[182],"differences":[183],"process":[186],"utilization.":[187],"Mutational":[188],"processes":[189,514],"associated":[190,224,278,444,513],"spontaneous":[191,241],"deamination":[192,244],"5-methylcytosine":[194],"thymine":[196],"was":[197,204,213,266],"in":[200,207,216,231,249,292,304,342,380,413,457,522,575,583],"HMM,":[201],"APOBEC":[202,264],"activity":[203,265,288],"very":[205],"strong":[206],"DNA":[211,511,549],"repair":[212,286,320,364],"t(6;14),":[217],"del17p":[218],"t(11;14).":[220],"Importantly,":[221],"mutations":[223,277,295,488],"clonal":[226],"cell":[227,236],"population":[228],"thus":[230],"early":[232],"phases":[233],"progression":[237],"driven":[239],"enzymatic":[243],"(Signature":[245,252],"1),":[246],"somatic":[247],"hypermutation":[248],"lymphoid":[250],"9)":[253],"Signature":[255],"17":[256],"(ANOVA":[257,271,296],"p":[258,272,297,386,409,505,529],"value":[259,273,298,387,410,506,530],"1e-16)":[261,300],"surprisingly":[263,496],"constant":[267],"among":[268],"clones":[270],">":[274],"0.05).":[275],"homologous":[280,318],"recombination":[281,319],"(HR)":[282],"nucleotide":[284],"excision":[285],"(NER)":[287],"enriched":[291],"subclonal":[294],"suggesting":[301],"their":[302],"role":[303,572],"later":[305],"stages":[306],"progression.":[309],"Based":[310],"on":[311,596,607,620,631,642,659,672],"information,":[313],"we":[314,400,541],"next":[315,391],"calculated":[316],"defects":[321],"WGS":[327,336],"data.":[328,538],"identified":[330,351,430],"HR":[332,574],"score":[333],"generated":[334],"information":[339],"predicted":[340,515,561],"newly":[343,353],"diagnosed":[344,354],"myeloma.":[345],"Further":[346],"analysis":[347],"hyperdiploid":[358],"no":[362],"HR-":[363],"deficiency":[365],"superior":[367],"6":[370],"year":[371],"overall":[372],"(OS)":[374],"probability":[375,404],"100%":[379],"IFM/DFCI":[381],"2009":[382],"cohort":[383],"(Logrank":[384,407],"0.0012).":[389],"validated":[392],"finding":[394],"MMRF":[396],"CoMMpass":[397],"dataset":[398,416],"confirmed":[401],"6-yr":[402],"OS":[403],"95%":[406],"0.0016)":[412],"independent":[415],"(Figure":[417],"1).":[418],"further":[420,534],"investigated":[421],"RNAseq":[422],"between":[424],"these":[425],"genomically":[426],"groups":[428],"chromosome":[432],"telomere":[434],"maintenance":[435],"pathways":[436],"(FDR":[437,451],"0.01)":[439],"low":[441],"bone":[442],"disease":[443],"genes":[445],"Zhan":[448],"et":[449],"al.":[450],"0.004)":[453],"up":[455],"regulated":[456],"low-risk":[458,524],"group.":[459],"Finally,":[460],"who":[462],"able":[464],"maintain":[466],"HR,":[467],"mutation":[470,498],"rate":[471,499],"TP53":[473],"(0%":[474,481],"vs":[475,482,490,503],"9%,":[476],"0.05),":[479,486,494],"CSMD1":[480],"6%,":[483],"FAT3/FAT4":[487],"(1.7%":[489],"15%,":[491],"however":[495],"higher":[497],"NRAS":[501],"(42%":[502],"14%,":[504],"0.001).":[508],"addition,":[510],"damage":[512],"SNVs":[517],"trinucleotides":[518],"(12%":[526],"vs.":[527],"20%,":[528],"1e-05)":[532],"providing":[533],"support":[535],"conclusion,":[540],"report":[542],"detailed":[544],"profile":[546],"RNA":[551],"genomically-defined":[556],"sub":[557],"This":[567],"study":[568],"identifies":[570],"myeloma":[576],"potential":[578],"its":[580],"translational":[581],"application":[582],"prognosis":[585],"as":[586,588],"well":[587],"therapy.":[589],"Figure":[590],"1":[591],"Disclosures":[592],"Richardson:":[593],"Janssen:":[594,684,717,759],"Membership":[595,606,619,630,641,658,671],"entity's":[598,609,622,633,644,661,674],"Board":[599,610,623,634,645,662,675],"Directors":[601,612,625,636,647,664,677],"advisory":[603,614,627,638,649,666,679],"committees;":[604,628,639],"Oncopeptides:":[605],"committees,":[615,650,667],"Research":[616,651,655,668,736,745],"Funding;":[617,652,656,669,737],"Sanofi:":[618],"Karyopharm:":[629],"Celgene:":[640,725,755],"Bristol-Myers":[653,704],"Squibb:":[654,705],"Takeda:":[657,690,721],"Amgen:":[670,687,713,753],"committees.":[680],"Moreau:Celgene:":[681],"Consultancy,":[682,685,688,691,694,714,718,722,726,730,739],"Honoraria;":[683,686,689,692],"AbbVie:":[693],"Honoraria.":[695],"Thakurta:Celgene:":[696],"Employment,":[697],"Equity":[698],"Ownership.":[699],"Anderson:Sanofi-Aventis:":[700],"Other:":[701,706,710,731,740],"Advisory":[702],"Board;":[703],"Scientific":[707,711],"Founder;":[708,712],"Oncopep:":[709,749],"Speakers":[715,719,723,727],"Bureau;":[716,720,724],"Bureau.":[728],"Avet-Loiseau:celgene:":[729],"travel":[732,741],"fees,":[733,735,742,744],"lecture":[734,743],"takeda:":[738],"Funding.":[746],"Munshi:Takeda:":[747],"Consultancy;":[748,750,752,754,756,758],"Adaptive:":[751],"Abbvie:":[757],"Consultancy.":[760]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2019-11-22T00:00:00"}